Active	Status	Sponsor type	Region	Phase	Filter
10 Active 5 Inactive 15 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

10 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Hill, Christopher
ACHIEVE, NCT03020303 / 2020-001882-36: Aldosterone BloCkade for Health Improvement EValuation in End-stage Renal Disease	Recruiting	3	2750	Europe, Canada, RoW	Spironolactone 25Mg Tablet, Placebo Oral Tablet	Population Health Research Institute, Canadian Institutes of Health Research (CIHR)	Endstage Renal Disease	07/25	04/26
NCT05517005: An Exploratory Investigation of a B12 Vitamin to Increase Energy and Focus	Completed	N/A	38	US	Hype Bites Supplement	Sourse, Citruslabs	B12 Deficiency Vitamin, Energy Supply; Deficiency, Mood	09/22	09/22
NCT05520424: An Exploratory Investigation of a Supplement to Promote Brain Health	Completed	N/A	40	US	The Daily Supplement	Parable, Citruslabs	Memory Deficits, Cognitive Change, Stress	10/22	10/22
NCT05528094: An Exploratory Investigation of a Supplement to Support Student Learning	Completed	N/A	38	US	GeniusDrops	JoySpring, Citruslabs	Concentration Ability Impaired, Mental Fatigue	12/22	12/22
NCT05617287: An Exploratory Investigation of Dietary Supplementation and the Effect on Common Symptoms of Perimenopause and Menopause	Completed	N/A	42	US	Semaine Menopause Supplement	Semaine Health, Citruslabs	Menopause, Menopause Related Conditions, Perimenopausal Disorder	01/23	01/23
NCT05520411: Examining the Effectiveness of Digestive Enzymes at Reducing Bloating and Stomach Distension	Completed	N/A	25	US	HUM Flatter Me	HUM Nutrition, Inc., Citruslabs	Stomach Distended, Bloating	01/23	01/23
Allen, Patrick
ABX464-105, NCT05507203: ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1	Recruiting	3	612	Europe, Canada, US, RoW	ABX464, Obefazimod, Placebo	Abivax S.A.	Ulcerative Colitis	03/25	04/25
ABTECT, NCT05535946: - Maintenance	Recruiting	3	1050	Europe, Canada, Japan, US, RoW	ABX464, Obefazimod, Placebo	Abivax S.A.	Ulcerative Colitis	01/26	01/30
NCT06233461: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease	Recruiting	2	268	Europe, Canada, Japan, US, RoW	TAK-279, Zasocitinib, Placebo	Takeda	Crohn's Disease	09/26	07/27
NCT06254950: A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis	Recruiting	2	207	Europe, Canada, Japan, US, RoW	TAK-279, Zasocitinib, Placebo	Takeda	Ulcerative Colitis	09/26	08/27
McAllister, Sandra E
No trials found